Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly (ACTIVATE)
A Randomized Clinical Trial for Enhanced Trained Immune Responses Through Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
Sponsor: Hellenic Institute for the Study of Sepsis
Listed as NCT03296423, this PHASE4 trial focuses on Hospitalization and Infection and remains completed. Sponsored by Hellenic Institute for the Study of Sepsis, it has been updated 10 times since 2017, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Feb 2021 — Mar 2022 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
-
Mar 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Mar 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hellenic Institute for the Study of Sepsis
- Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .